Hepatic fibrosis as wound repair: A progress report

Journal of Gastroenterology

Volumn 33, Issue 2, 1998, Pages 295-302

  Bissell, D Montgomery ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Extracellular matrix; Fibronectin; Ito cell; Lipocyte; Review; Stellate cell

Indexed keywords

CELL RECEPTOR; CYTOKINE; DICARBOXYLIC ACID DERIVATIVE; ENDOTHELIN; GAMMA INTERFERON; INTEGRIN; OXYGEN RADICAL; SAFIRONIL; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; AUTOCRINE EFFECT; CELL ACTIVATION; CELL COMMUNICATION; CELL INFILTRATION; CELL MIGRATION; CELL PROLIFERATION; DRUG DESIGN; FIBROGENESIS; HUMAN; LIVER DYSFUNCTION; LIVER FIBROSIS; LIVER INJURY; MYOFIBROBLAST; NONHUMAN; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; STELLATE CELL; WOUND HEALING;

CELL MOVEMENT; EXTRACELLULAR MATRIX; HUMANS; HYPERTENSION, PORTAL; LIVER; LIVER CIRRHOSIS; NEOVASCULARIZATION, PATHOLOGIC; WOUND HEALING;

EID: 0031939554     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350050087     Document Type: Review

References (60)

1. Maher JJ, Scott MK, Saito JM, et al. Adenovirus-mediated expression of cytokine-induced neutrophil chemoattractant in rat liver induces a neutrophilic hepatitis. Hepatology 1997;25:624-630.
2. Pietrangelo A. Metals, oxidative stress, and hepatic fibrogenesis. Semin Liver Dis 1996;16:13-30.
3. Kocher O, Kennedy SP, Madri JA. Alternative splicing of endothelial cell fibronectin mRNA in the IIICS region. Functional significance. Am J Pathol 1990;137:1509-1524.
4. Bachem MG, Meyer D, Melchior R, et al. Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. A potential mechanism of self perpetuation in liver fibrogenesis. J Clin Invest 1992;89:19-27.
5. O'Kane S, Ferguson MW. Transforming growth factor betas and wound healing. Int J Biochem Cell Biol 1997;29:63-78.
6. Bottinger EP, Letterio JJ, Roberts AB. Biology of TGF-beta in knockout and transgenic mouse models. Kidney Int 1997;51:1355-1360.
7. Bissell DM, Wang SS, Jarnagin WR, et al. Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. J Clin Invest 1995;96:447-455.
8. De Bleser PJ, Niki T, Rogiers V, et al. Transforming growth factor-beta gene expression in normal and fibrotic rat liver. J Hepatol 1997;26:886-893.
9. Lawrence DA. Transforming growth factor-beta: A general review. Eur Cytokine Network 1996;7:363-374.
10. Cosgrove D, Meehan DT, Grunkemeyer JA, et al. Collagen COL4A3 knockout: A mouse model for autosomal Alport syndrome. Genes Devel 1996;10:2981-2992.
11. Georges-Labouesse EN, George EL, Rayburn H, Hynes RO. Mesodermal development in mouse embryos mutant for fibronectin. Devel Dynam 1996;207:145-156.
12. Sympson CJ, Talhouk RS, Alexander CM, et al. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J Cell Biol 1994;125:681-693.
13. Mars WM, Liu ML, Kitson RP, et al. Immediate early detection of urokinase receptor after partial hepatectomy and its implications for initiation of liver regeneration. Hepatology 1995;21:1695-1701.
14. Singhvi R, Kumar A, Lopez GP, et al. Engineering cell shape and function. Science 1994;264:696-698.
15. Jarnagin WR, Rockey DC, Koteliansky VE, et al. Expression of variant fibronectins in wound healing: Cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol 1994;127:2037-2048.
16. Geerts A, Schuppan D, Lazeroms S, et al. Collagen type I and III occur together in hybrid fibrils in the space of Disse of normal rat liver. Hepatology 1990;12:233-241.
17. Liu X, Wu H, Byrne M, et al. Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development. Proc Natl Acad Sci USA 1997;94:1852-1856.
18. Vyas SK, Leyland H, Gentry J, Arthur MJ. Rat hepatic lipocytes synthesize and secrete transin (stromelysim) in early primary culture. Gastroenterology 1995;109:889-898.
19. Johnatty RN, Taub DD, Reeder SP, et al. Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes. J Immunol 1997;158:2327-2333.
20. Wei Y, Lukashev M, Simon DI, et al. Regulation of integrin function by the urokinase receptor. Science 1996;273:1551-1555.
21. Wong L, Yamasaki G, Johnson RJ, et al. Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. J Clin Invest 1994;94:1563-1569.
22. Gressner AM, Lahme B, Brenzel A. Molecular dissection of the mitosenic effect of hepatocytes on cultured hepatic stellate cells. Hepatology 1995;22:1507-1518.
23. Bachem MG, Meyer D, Melchior R, et al. Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. A potential mechanism of self perpetuation in liver fibrogenesis. J Clin Invest 1992;89:19-27.
24. Bhunchet E, Fujieda K. Capitalization and venularization of hepatic sinusoids in porcine serum-induced rat liver fibrosis: A mechanism to maintain liver blood flow. Hepatology 1993;18:1450-1458.
25. Rana B, Mischoulon D, Xie Y, et al. Cell-extracellular matrix interactions can regulate the switch between growth and differentiation in rat hepatocytes: Reciprocal expression of OEBP alpha and immediate-early growth response transcription factors. Mol Cell Biol 1994;14:5858-5869.
26. Reeves HL, Burt AD, Wood S, et al. Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis. J Hepatol 1996;25:677-683.
27. Demirci G, Nashan B, Pichlmayr R. Fibrosis in chronic rejection of human liver allografts: Expression patterns of transforming growth factor-TGFbeta1 and TGF-beta3. Transplantation 1996;62:1776-1783.
28. Leyland H, Gentry J, Arthur MJ, et al. The plasminogen-activating system in hepatic stellate cells. Hepatology 1996;24:1172-1178.
29. Housset C, Rockey DC, Bissell DM. Endothelin receptors in rat liven Lipocytes as a contractile target for endothelin 1. Proc Natl Acad Sci USA 1993;90:9266-9270.
30. Rockey DC, Chung JJ. Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing. J Clin Invest 1996;98:1381-1388.
31. Senoo H, Imai K, Sato M, et al. Three-dimensional structure of extracellular matrix reversibly regulates morphology, proliferation and collagen metabolism of perisinusoidal stellate cells (vitamin A-storing cells). Cell Biol Internat 1996;20:501-512.
32. Baker AJ, Mooney A, Hughes J, et al. Mesangial cell apoptosis: The major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 1994;94:2105-2116.
33. Rojkind M, Dunn MA. Hepatic fibrosis. Gastroenterology 1979;76:849-863.
34. Ogata S, Takeda M, Lee MJ, et al. Histopathological sequence of hepatic and renal lesions in rats after cessation of the repeated administration of CC14. Exp Toxicol Pathol 1995;47:493-499.
35. Morcos SH, Khayyal MT, Mansour MM, et al. Reversal of hepatic fibrosis after praziquantel therapy of murine schistosomiasis. Am J Trop Med Hyg 1985;34:314-321.
36. Lesur G, Levy P, Flejou JF, et al. Factors predictive of liver histopathological appearance in chronic alcoholic pancreatitis with common bile duct stenosis and increased serum alkaline phosphatase. Hepatology 1993;18:1078-1081.
37. Bloomer JR. The liver in protoporphyria. Hepatology 1988;8:402-407.
38. Strader DB, Seeff LB. The natural history of chronic hepatitis C infection. Eur J Gastro Hepatol 1996;8:324-328.
39. Perez-Tamayo R, Montfort I, Gonzalez E. Collagenolytic activity in experimental cirrhosis of the liver, Exp Mol Pathol 1987;47:300-308.
40. Ernst O, Sergent G, Bonvarlet P, et al. Hepatic iron overload: Diagnosis and quantification with MR imaging. AJR Am J Roentgenol 1997;168:1205-1208.
41. Shimizu H, He W, Guo P, et al. Serum hyaluronate in the assessment of liver endothelial cell function after orthotopic liver transplantation in the rat. Hepatology 1994;20:1323-1329.
42. Pares A, Deulofeu R, Gimenez A, et al. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis. Hepatology 1996;24:1399-1403.
43. Bissell DM, Arenson DM, Maher JJ, et al. Support of cultured hepatocytes by a laminin-rich gel. Evidence for a functionally significant subendothelial matrix in normal rat liver. J Clin Invest 1987;79:801-812.
44. Berthiaume F, Moghe PV, Toner M, et al. Effect of extracellular matrix topology on cell structure, function, and physiological responsiveness: Hepatocytes cultured in a sandwich configuration. FASEB J 1996;10:1471-1484.
45. Bucher NL, Robinson GS, Farmer SR. Effects of extracellular matrix on hepatocyte growth and gene expression: implications for hepatic regeneration and the repair of liver injury. Semin Liver Dis 1990;10:11-19.
46. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. New Engl J Med 1994;331:1286-1292.
47. George J, Wang FS, Sanicola M, et al. In vivo regulation of [EIIIA] fibronectin expression by transforming growth factor β during rat hepatic fibrogenesis (abstract). Gastroenterology 1997;1270.
48. Lortat-Jacob H, Baltzer F, Desmouliere A, et al. Lobular - but not periovular - inhibition of collagen deposition in the liver of S. mansoni infected mice using interferon-gamma. J Hepatol 1997;26:894-903.
49. Baroni GS, D'Ambrosio L, Curto P, et al. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. Hepatology 1996;23:1189-1199.
50. Sakaida I, Matsumura Y, Kubota M, et al. The prolyl 4-hydroxylase inhibitor HOE 077 prevents activation of Ito cells, reducing procollagen gene expression in rat liver fibrosis induced by choline-deficient 1-amino acid-defined diet. Hepatology 1996;23:755-763.
51. Wang YJ, Wang SS, Bickel M, et al. Mechanism of action of HOE077 - a novel antifibrotic with sex-specific effects in liver. Am J Pathol 1997.
52. Racine-Samson R, Rockey DC, Bissell DM. Expression of the collagen-binding integrins α1β1 and α2β1 during activation of rat hepatic stellate cells in vivo. J Biol Chem 1997.
53. Gardner H, Kreidberg J, Koteliansky V, et al. Deletion of integrin alpha 1 by homologous recombination permits normal murine development but gives rise to a specific deficit in cell adhesion. Dev Biol 1996;175:301-313.
54. Isaka Y, Brees DK, Ikegaya K, et al. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nature Medicine 1996;2:418-423.
55. Roeb E, Rose-John S, Erren A, et al. Tissue inhibitor of metalloproteinases-2 (TIMP-2) in rat liver cells is increased by lipopolysaccharide and prostaglandin E2. FEBS Lett 1995;357:33-36.
56. Knook DL, Bosma A, Seifert WF. Role of vitamin A in liver fibrosis. J Gastro Hepatol 1995;10(Suppl 1):S47-49.
57. Brown KE, Poulos JE, Li L, et al. Effect of vitamin E supplementation on hepatic fibrogenesis in chronic dietary iron overload. Am J Physiol 1997;272:G116-123.
58. Pinzani M, Carloni V, Marra F, et al. Biosynthesis of platelet-activating factor and its 1O-acyl analogue by liver fat-storing cells. Gastroenterology 1994;106:1301-1311.
59. Zhang HY, Gharaee-Kermani M, Phan SH. Regulation of lung fibroblast alpha-smooth muscle actin expression, contractile phenotype, and apoptosis by IL-1 beta. J Immunol 1997;158: 1392-1399.
60. Rockey DC, Chung JJ. Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing. J Clin Invest 1996;98:1381-1388.